Summary:
Evaluation of an Investigational RNA-based COVID Vaccine in Healthy Adults with Previous COVID Vaccine Exposure - COVID Booster Study
Qualified Participants May Receive:
Will receive access to medical professionals; will receive up to $1,060 in compensation for time and travel
Qualified participants will receive trial vaccine